Medicare and Medicaid Programs; Repeal of Minimum Staffing Standards for Long-Term Care Facilities
Comment: Submitted to Centers for Medicare & Medicaid Services
Population Health
Policy
Patient Focused Drug Development: Methodologic and Other Challenges Related to Patient Experience Data
Comment: Submitted to the Food and Drug Administration and Department of Health and Human Services
Print:
On December 18, 2024, LDI Senior Fellow Sean Hennessy, PharmD, PhD submitted a comment in response to a Request for Comments from the U.S Food and Drug Administration and U.S. Department of Health and Human Services. The request sought input regarding methodological challenges related to data on patient experience.
As an expert in pharmacoepidemiology, the study of the health effects of drugs and other medical products in populations, Dr. Hennessy provides 10 suggestions for improving the use of patient experience data in patient focused drug development.
Views expressed by the researchers are their own and do not necessarily represent those of the University of Pennsylvania Health System (Penn Medicine) or the University of Pennsylvania.
More on Policy at LDI
Analysis of the Rural Health Transformation Program
Memo: Response to Request for Analysis
Employment Protections for Individuals Experiencing Menstruation, Perimenopause, or Menopause
Testimony: Delivered to Philadelphia City Council’s Committee on Health and Human Services
Health Benefits of Philadelphia’s Sweetened Beverage Tax
Testimony: Delivered to Philadelphia City Council’s Committee on Labor and Civil Service
Complementary and Integrative Approaches to Pain Management
Comment: Delivered to the National Center for Complementary and Integrative Health
Exclusion of Abortion and Abortion Counseling from the VA Medical Benefits Package
Comment: Submitted to the U.S. Department of Veterans Affairs